Ginkgo Bioworks DNA Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's common stock, par value (in dollars per share)?
- Ginkgo Bioworks (DNA) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Ginkgo Bioworks's common stock, par value (in dollars per share) changed year-over-year?
- Ginkgo Bioworks's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Ginkgo Bioworks's common stock, par value (in dollars per share)?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.